Facebook Pixel Code

Suven Pharmaceuticals Ltd. Share Price

NSE
BSE

SUVEN PHARMACEUTICALS LTD.

Sector : Pharmaceuticals | Smallcap | BSE

Suven Pharmaceuticals Ltd., operating in the Pharmaceuticals sector and classified as a Smallcap on the bse, currently has its share price at 780.5 The stock has experienced fluctuations today, with a low of ₹727.05 and a high of ₹807.9 Over the past 52 weeks, the shares have seen a low of ₹427.05 and a high of ₹767.

In terms of performance, Suven Pharmaceuticals Ltd. has shown a return of 6.94% in one day, 23.19% over the past month, and 21.95% in the last three months.

Analyzing the technicals, the daily pivot level for the stock is set at 768.97. The resistance levels are identified as R1 at 810.88, R2 at 833.92, and R3 at 875.83. On the support side, the levels are marked as S1 at 745.93, S2 at 704.02, and S3 at 680.98.

In the realm of technical analysis for our subject stock, the moving averages present a detailed picture. Over a short span of 5 days, the Simple Moving Average (SMA) stands at 697.53, while the Exponential Moving Average (EMA) is noted at 718.99. Extending the view to a 10-day period, the SMA adjusts to 670.12 with the EMA slightly differing at 708.43.

In a comparative analysis of stock performance within its sector, Suven Pharmaceuticals Ltd. stands alongside several key competitors, each showcasing varied performance metrics over different time periods. Suven Pharmaceuticals Ltd. itself has recorded performance figures of 1W % is 7.69 over the past week, 23.11% in the last month, and 21.87% over the past three months. Its six-month, one-year, three-year, and five-year performances are 6 month % is 11.8, 1yr % is 60.08, 3Y % is 64.5, and 5Y % is 363.99 respectively.

Read More  

₹780.50
7.0151.15
As on Jun 27, 2024, 2:22 PM | IST
Intraday
1 Week
1 Month
3 Months
6 Months
1 Year

Suven Pharmaceuticals Ltd. Performance

Today's LowToday's High
₹727.05₹807.90
₹780.50
52 Weeks' Low52 Weeks' High
₹427.05₹767.00
₹780.50
Open Price
₹727.05
Prev. Close
₹729.35
Volume
1,12,669

Suven Pharmaceuticals Ltd. Technicals

Pivot Level

  • R1810.88
  • R2833.92
  • R3875.83
  • Pivot
    768.97
  • S1745.93
  • S2704.02
  • S3680.98

Moving Average

  • DaySMAEMA
  • 5697.53718.99
  • 10670.12708.43
  • 20650.09689.33
  • 50647.52667.79
  • 100652.18656.22
  • 200631.21629.33

Suven Pharmaceuticals Ltd. Peer Comparision

Stock Performance
Ratio Performance
Name
1W%
1M%
3M%
6M%
1Y%
3Y%
5Y%
7.6923.1121.8711.8060.0864.50363.99
2.622.88-6.1620.5550.64123.14274.63
0.536.4834.6216.6026.385.03182.56
-4.81-0.550.2718.6145.7052.72166.33
-2.96-0.165.7353.4885.1464.53344.24
4.035.422.588.5923.4814.79142.10
-3.004.608.2722.4247.8588.91263.00
-4.08-0.70-9.984.7525.1447.4847.48
1.63-2.18-1.1122.6179.4335.77106.99
-4.32-0.5311.1511.2065.6422.8794.20
-4.05-7.24-0.95-2.3945.7458.28194.28
2.344.912.9422.0121.3763.18208.96
4.6312.0740.4045.8684.4472.93116.83
0.559.6434.4936.7041.64-14.6238.99
-1.648.9926.7944.4086.1883.11172.33
-1.87-3.45-1.09-7.5977.40-44.60-1.13
-1.10-4.836.1615.9854.5073.14263.75
-2.91-15.62-8.733.3148.628.52136.42
-6.65-5.402.403.8144.50105.57820.79
-2.46-4.307.60-2.3515.08-37.60519.40

Suven Pharmaceuticals Ltd. Share Holdings

Suven Pharmaceuticals Ltd. Mutual Fund Holdings

Fund Name
No. Of Shares
% of AUM
Amount Invested
(in ₹ crore)
UTI Flexi Cap Fund38,12,6460.98235.35
DSP ELSS Tax Saver Fund31,93,6321.3197.14
DSP Healthcare Fund28,93,5057.56178.62
DSP Equity Opportunities Fund24,07,2981.24148.6
HSBC Small Cap Fund - Regular Plan22,98,0850.96141.86
DSP Equity & Bond Fund20,33,4521.37125.53
Tata Small Cap Fund20,00,0001.74123.46
DSP Flexi Cap Fund19,91,5101.16122.94
UTI Value Fund17,66,9901.2109.08
Canara Robeco Small Cap Fund16,75,9830.99103.46
View All Mutual Funds

Suven Pharmaceuticals Ltd. Corporate Actions

Announcement
Board Meetings
Dividend
Bonus
AGM
  • Suven Pharmaceutical - Transcript Of The Conference Call For Acquisition Of A Majority Stake In Sapala Organics
    Transcript of the conference call for acquisition of a majority stake in Sapala Organics
    21-Jun, 2024 | 05:50 PM
  • Suven Pharmaceutical - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and with reference to our conference call intimation dated June 13, 2024, the audio recording of the conference call for acquisition of a majority stake in Sapala Organics held on Wednesday, June 19, 2024, has beenuploaded on the Company''s website
    19-Jun, 2024 | 06:56 PM
  • Suven Pharmaceutical - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regu
    The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on June 18, 2024 for Berhyanda Ltd & Berhyanda Midco Ltd
    19-Jun, 2024 | 12:03 AM
  • Suven Pharmaceutical - Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And
    Update on amalgamation of Casper Pharma Pvt Ltd (WOS) into and with Suven Pharmaceuticals Limited is attached.
    15-Jun, 2024 | 01:44 PM
  • Suven Pharmaceutical - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Conference Call
    13-Jun, 2024 | 06:48 PM

About Suven Pharmaceuticals Ltd.

Suven Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 06/11/2018 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L24299TG2018PLC128171 and registration number is 128171. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1320.22 Cr. and Equity Capital is Rs. 25.46 Cr. for the Year ended 31/03/2022.

Management

  • Mr. Annaswamy Vaidheesh
    Executive Chairman
  • Mr. V Prasada Raju
    Managing Director
  • Mr. Pankaj Patwari
    Non Exe.Non Ind.Director
  • Ms. Shweta Jalan
    Non Exe.Non Ind.Director
  • Ms. Matangi Gowrishankar
    Independent Director
  • Mr. Vinod Rao
    Independent Director
  • Mr. K G Ananthakrishnan
    Independent Director
  • Mr. Pravin Rao Udhyavara Bhadya#
    Independent Director

FAQs on Suven Pharmaceuticals Ltd.

What is the Market Cap of Suven Pharmaceuticals Ltd.?

The market cap of Suven Pharmaceuticals Ltd. is ₹18,630.34 Cr as on Jun 27, 2024.

What is the PE and PB Ratio of Suven Pharmaceuticals Ltd.?

P/E ratio of Suven Pharmaceuticals Ltd. is 62.04 and PB ratio of Suven Pharmaceuticals Ltd. is 9.09 as on Jun 27, 2024.

What is the share price of Suven Pharmaceuticals Ltd.?

The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Suven Pharmaceuticals Ltd. is ₹780.50 as on Jun 27, 2024.

What are the 52 Week High and 52 Week Low of Suven Pharmaceuticals Ltd.?

The 52-week high/low is the highest and lowest price at which Suven Pharmaceuticals Ltd. stock has traded in the past 52-week or nearly a year. The 52-week high of Suven Pharmaceuticals Ltd. is ₹767.00 and 52-week low of Suven Pharmaceuticals Ltd. is ₹427.05 as on Jun 27, 2024.

icon
Market Data